Fund Details
AB
Arkin Bio Ventures
11 Hamenofim Str. Building B, 9th floor, Herzliya, 4672562, Israel
Overview
Investment portfolio
30rounds
| NAME | DATE | SIZE | |
|---|---|---|---|
Plantopia | Jul 2026Participated | $9 MOther Equity | |
Hemispheric | Jul 2026Participated | $52 MOther Equity | |
Bionyra Pharma | Jun 2026Participated | $165 MSeries A | |
Shifters | Jun 2026Participated | $10 MSeed | |
Stark Power | Apr 2026Participated | $68 MOther Equity | |
Crossbow Therapeutics | Mar 2026Led | $77 MSeries B | |
Nocion Therapeutics | Jan 2026Led | $23 MSeries B | |
Ambros Therapeutics | Dec 2025Participated | $125 MSeries A | |
CyberRidge | Oct 2025Participated | $26 MSeed | |
QuamCore | Aug 2025Participated | $26 MSeries A | |
Actithera | Jul 2025Participated | $76 MSeries A | |
Newleos Therapeutics | Feb 2025Participated | $94 MSeries A | |
Plantopia | Jul 2026Participated | $9 MOther Equity | |
Hemispheric | Jul 2026Participated | $52 MOther Equity | |
Bionyra Pharma | Jun 2026Participated | $165 MSeries A | |
Shifters | Jun 2026Participated | $10 MSeed | |
Stark Power | Apr 2026Participated | $68 MOther Equity | |
Crossbow Therapeutics | Mar 2026Led | $77 MSeries B | |
Nocion Therapeutics | Jan 2026Led | $23 MSeries B | |
Ambros Therapeutics | Dec 2025Participated | $125 MSeries A | |
CyberRidge | Oct 2025Participated | $26 MSeed | |
QuamCore | Aug 2025Participated | $26 MSeries A | |
Actithera | Jul 2025Participated | $76 MSeries A | |
Newleos Therapeutics | Feb 2025Participated | $94 MSeries A |
30 Items
30
Items
...
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 1 | 2 |
| Series A | 1 | 11 |
| Series B | 4 | 6 |
| Series C+ | 0 | 2 |
| Other Equity | 0 | 3 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Dec '16 | 1 |
| Jan '17 | 0 |
| Feb '17 | 0 |
| Mar '17 | 0 |
| Apr '17 | 0 |
| May '17 | 0 |
| Jun '17 | 0 |
| Jul '17 | 0 |
| Aug '17 | 0 |
| Sep '17 | 0 |
| Oct '17 | 0 |
| Nov '17 | 0 |
| Dec '17 | 0 |
| Jan '18 | 0 |
| Feb '18 | 0 |
| Mar '18 | 0 |
| Apr '18 | 0 |
| May '18 | 0 |
| Jun '18 | 0 |
| Jul '18 | 0 |
| Aug '18 | 0 |
| Sep '18 | 0 |
| Oct '18 | 0 |
| Nov '18 | 0 |
| Dec '18 | 0 |
| Jan '19 | 1 |
| Feb '19 | 0 |
| Mar '19 | 0 |
| Apr '19 | 0 |
| May '19 | 1 |
| Jun '19 | 0 |
| Jul '19 | 0 |
| Aug '19 | 1 |
| Sep '19 | 0 |
| Oct '19 | 0 |
| Nov '19 | 1 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 1 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 0 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 1 |
| Jan '21 | 2 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 1 |
| Aug '22 | 1 |
| Sep '22 | 1 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 1 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 1 |
| Feb '24 | 1 |
| Mar '24 | 1 |
| Apr '24 | 0 |
| May '24 | 2 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 1 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 1 |
| Aug '25 | 1 |
| Sep '25 | 0 |
| Oct '25 | 1 |
| Nov '25 | 0 |
| Dec '25 | 1 |
| Jan '26 | 1 |
| Feb '26 | 0 |
| Mar '26 | 1 |
| Apr '26 | 1 |
| May '26 | 0 |
| Jun '26 | 2 |
| Jul '26 | 2 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 25 |
| Space & Frontier Tech | 4 |
| Hardware & Robotics | 3 |
| AI & Machine Learning | 2 |
| Networks, Cloud & Communication | 1 |
| Cybersecurity & Privacy | 1 |
| Food & Agriculture | 1 |
| Clean Energy & Sustainability | 1 |
| Data, Analytics & IT | 1 |
| Consumer & Lifestyle | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 1 |
| $5M-$10M | 1 |
| $10M-$25M | 6 |
| $25M-$50M | 6 |
| $50M-$100M | 12 |
| $100M-$250M | 4 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 4 of 4 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 20 |
| Israel | 7 |
| Europe | 2 |
| Canada | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| MPM Capital | 8 |
| Eli Lilly and Company | 4 |
| Longwood Fund | 4 |
| 4BIO Capital | 3 |
| Deerfield Management | 3 |
| Mass General Brigham Ventures | 3 |
| Novo Holdings | 3 |
| Polaris Partners | 3 |
| Qiming Venture Partners USA | 3 |
| RA Capital Management | 3 |
| Sixty Degree Capital | 3 |
| Surveyor Capital | 3 |
| Taiho Ventures | 3 |
| Adage Capital Management | 2 |
| Apollo Health Ventures | 2 |
| Astellas Venture Management | 2 |
| BrightEdge | 2 |
| Canaan Partners | 2 |
| Casdin Capital | 2 |
| Celgene | 2 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 6 | 20% |
| Participating | 24 | 80% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 1 | 17% |
| Co-led | 5 | 83% |